Slovakia-focused Ortac Resources (OTC) has reported an encouraging set of results from its Sturec project.
The AIM-quoted concern declared that the results had shown consistent high grade intercepts with what it described as 'encouraging' widths. The strongest results included 87.9 metres grading at 6.95 grammes a tonne and 66.3 metres grading at 1.26 grammes a tonne.
Ortac argued that the results 'provide further confidence in the robustness of the Sturec resource mode' adding that it should help to enable 'future analysis for conversion of inferred resource ounces into higher indicated and measured categories'.
Chief executive officer Vassillios Carellas remarked that the results show that the 'recently completed scoping study is based on sound principals' noting that the high gold grades 'provide us with with required evidence to justify further drilling to the south of the Sturec fault' where there had been previously little mining activity.
Shares in Ortac were last recommended by Growth Company Investorlast November at 0.98p as a speculative buy. Currently trading at 0.86p the company is valued at £19.8 million
The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info
Latest small-cap and growth company news
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Technological innovations have seriously helped reshape the way in which we interact with the world and the people around us. And the smartphone has become a one-stop device for communication, travel, online browsing, taking photos, watching videos and even high-definition gaming.
Shares in clinical research organisation Venn Life Sciences are up around 5 per cent at the time of writing following the company's positive trading update ahead of its results announcement for the first half of the year on 22 September.